These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 8013162)

  • 21. Relationship between water compartments, body composition assessed by bioelectrical impedance analysis and blood pressure in school children.
    Łątka M; Wójtowicz K; Drożdż T; Dąbrowska E; Kwinta P; Pietrzyk JA; Drożdż D
    Przegl Lek; 2016; 73(1):1-5. PubMed ID: 27120940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
    Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection.
    Wilson IB; Jacobson DL; Roubenoff R; Spiegelman D; Knox TA; Gorbach SL
    HIV Med; 2002 Oct; 3(4):263-70. PubMed ID: 12444944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.
    Salazar DE; Corcoran GB
    Am J Med; 1988 Jun; 84(6):1053-60. PubMed ID: 3376975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new TOBEC instrument and procedure for the assessment of body composition: use of Fourier coefficients to predict lean body mass and total body water.
    Van Loan M; Mayclin P
    Am J Clin Nutr; 1987 Jan; 45(1):131-7. PubMed ID: 3799498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in pharmacokinetics in elderly patients].
    Nadai M; Katoh M
    Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can lean body mass be used to reduce the dose of heparin and protamine for obese patients undergoing cardiopulmonary bypass?
    Baker MS; Skoyles JR; Shajar FM; Skinner H; Richens D; Mitchell IM
    J Extra Corpor Technol; 2005 Jun; 37(2):153-6. PubMed ID: 16117451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical treatment guide for dose individualisation in cancer chemotherapy.
    Canal P; Chatelut E; Guichard S
    Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design.
    Rodman JH
    J Adolesc Health; 1994 Dec; 15(8):654-62. PubMed ID: 7696286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional assessment.
    Harrison JE; McNeill KG
    Blood Purif; 1994; 12(1):68-72. PubMed ID: 7986479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism-based concepts of size and maturity in pharmacokinetics.
    Anderson BJ; Holford NH
    Annu Rev Pharmacol Toxicol; 2008; 48():303-32. PubMed ID: 17914927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Existing equations to estimate lean body mass are not accurate in the critically ill: Results of a multicenter observational study.
    Moisey LL; Mourtzakis M; Kozar RA; Compher C; Heyland DK
    Clin Nutr; 2017 Dec; 36(6):1701-1706. PubMed ID: 27697303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of creatinine excretion in body-composition studies of healthy men and women older than 60 y.
    Welle S; Thornton C; Totterman S; Forbes G
    Am J Clin Nutr; 1996 Feb; 63(2):151-6. PubMed ID: 8561053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.